Atlas Trials

Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

Clinical trial NCT03196661 · COMPLETED

Trial details

NCT number
NCT03196661
Sponsor
Hualan Biological Bacterin Co. Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza A
Start date
2015-11-06
Primary completion
2016-07-05
Enrollment
588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.